nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentazocine—EBP—Treprostinil—Nadolol—hypertension	0.00485	1	CbGdCrCtD
Pentazocine—EBP—endocrine gland—hypertension	0.000202	0.118	CbGeAlD
Pentazocine—Hypersensitivity—Valsartan—hypertension	0.000187	0.00028	CcSEcCtD
Pentazocine—Dermatitis—Propranolol—hypertension	0.000187	0.00028	CcSEcCtD
Pentazocine—Diarrhoea—Verapamil—hypertension	0.000187	0.00028	CcSEcCtD
Pentazocine—Constipation—Irbesartan—hypertension	0.000187	0.00028	CcSEcCtD
Pentazocine—Dizziness—Doxazosin—hypertension	0.000186	0.000279	CcSEcCtD
Pentazocine—Feeling abnormal—Captopril—hypertension	0.000186	0.000279	CcSEcCtD
Pentazocine—Insomnia—Losartan—hypertension	0.000186	0.000278	CcSEcCtD
Pentazocine—Loss of consciousness—Timolol—hypertension	0.000186	0.000278	CcSEcCtD
Pentazocine—Constipation—Hydrochlorothiazide—hypertension	0.000185	0.000277	CcSEcCtD
Pentazocine—Decreased appetite—Furosemide—hypertension	0.000185	0.000277	CcSEcCtD
Pentazocine—Vision blurred—Lisinopril—hypertension	0.000185	0.000276	CcSEcCtD
Pentazocine—Paraesthesia—Losartan—hypertension	0.000185	0.000276	CcSEcCtD
Pentazocine—Dizziness—Fosinopril—hypertension	0.000184	0.000275	CcSEcCtD
Pentazocine—Tremor—Lisinopril—hypertension	0.000184	0.000275	CcSEcCtD
Pentazocine—Decreased appetite—Betaxolol—hypertension	0.000183	0.000275	CcSEcCtD
Pentazocine—Dyspnoea—Losartan—hypertension	0.000183	0.000274	CcSEcCtD
Pentazocine—Somnolence—Losartan—hypertension	0.000183	0.000274	CcSEcCtD
Pentazocine—Dizziness—Eplerenone—hypertension	0.000183	0.000274	CcSEcCtD
Pentazocine—Vomiting—Diltiazem—hypertension	0.000183	0.000273	CcSEcCtD
Pentazocine—Vomiting—Indapamide—hypertension	0.000183	0.000273	CcSEcCtD
Pentazocine—Asthenia—Valsartan—hypertension	0.000182	0.000273	CcSEcCtD
Pentazocine—Hypertension—Timolol—hypertension	0.000182	0.000273	CcSEcCtD
Pentazocine—Constipation—Furosemide—hypertension	0.000182	0.000273	CcSEcCtD
Pentazocine—Asthenia—Olmesartan—hypertension	0.000181	0.000272	CcSEcCtD
Pentazocine—Dizziness—Nifedipine—hypertension	0.000181	0.000272	CcSEcCtD
Pentazocine—Dermatitis—Indapamide—hypertension	0.000181	0.000271	CcSEcCtD
Pentazocine—Dermatitis—Diltiazem—hypertension	0.000181	0.000271	CcSEcCtD
Pentazocine—Vomiting—Carvedilol—hypertension	0.000181	0.000271	CcSEcCtD
Pentazocine—Feeling abnormal—Perindopril—hypertension	0.000181	0.00027	CcSEcCtD
Pentazocine—Dizziness—Verapamil—hypertension	0.000181	0.00027	CcSEcCtD
Pentazocine—Constipation—Betaxolol—hypertension	0.00018	0.00027	CcSEcCtD
Pentazocine—Feeling abnormal—Irbesartan—hypertension	0.00018	0.00027	CcSEcCtD
Pentazocine—Headache—Indapamide—hypertension	0.00018	0.000269	CcSEcCtD
Pentazocine—Headache—Diltiazem—hypertension	0.00018	0.000269	CcSEcCtD
Pentazocine—Pruritus—Valsartan—hypertension	0.00018	0.000269	CcSEcCtD
Pentazocine—Dry mouth—Ramipril—hypertension	0.00018	0.000269	CcSEcCtD
Pentazocine—Dermatitis—Carvedilol—hypertension	0.000179	0.000268	CcSEcCtD
Pentazocine—Pruritus—Olmesartan—hypertension	0.000179	0.000268	CcSEcCtD
Pentazocine—Vomiting—Doxazosin—hypertension	0.000179	0.000268	CcSEcCtD
Pentazocine—Decreased appetite—Losartan—hypertension	0.000179	0.000268	CcSEcCtD
Pentazocine—Feeling abnormal—Hydrochlorothiazide—hypertension	0.000179	0.000267	CcSEcCtD
Pentazocine—Hypersensitivity—Clonidine—hypertension	0.000179	0.000267	CcSEcCtD
Pentazocine—Headache—Carvedilol—hypertension	0.000178	0.000267	CcSEcCtD
Pentazocine—Confusional state—Ramipril—hypertension	0.000178	0.000266	CcSEcCtD
Pentazocine—Dermatitis—Doxazosin—hypertension	0.000177	0.000265	CcSEcCtD
Pentazocine—Vomiting—Fosinopril—hypertension	0.000177	0.000265	CcSEcCtD
Pentazocine—Nausea—Propranolol—hypertension	0.000176	0.000264	CcSEcCtD
Pentazocine—Anaphylactic shock—Ramipril—hypertension	0.000176	0.000264	CcSEcCtD
Pentazocine—Headache—Doxazosin—hypertension	0.000176	0.000264	CcSEcCtD
Pentazocine—Vertigo—Lisinopril—hypertension	0.000176	0.000264	CcSEcCtD
Pentazocine—Dry mouth—Timolol—hypertension	0.000176	0.000263	CcSEcCtD
Pentazocine—Constipation—Losartan—hypertension	0.000176	0.000263	CcSEcCtD
Pentazocine—Syncope—Lisinopril—hypertension	0.000176	0.000263	CcSEcCtD
Pentazocine—Vomiting—Eplerenone—hypertension	0.000176	0.000263	CcSEcCtD
Pentazocine—Feeling abnormal—Furosemide—hypertension	0.000176	0.000263	CcSEcCtD
Pentazocine—Dermatitis—Fosinopril—hypertension	0.000175	0.000262	CcSEcCtD
Pentazocine—Vomiting—Nifedipine—hypertension	0.000174	0.000261	CcSEcCtD
Pentazocine—Headache—Fosinopril—hypertension	0.000174	0.000261	CcSEcCtD
Pentazocine—Hypersensitivity—Trandolapril—hypertension	0.000174	0.000261	CcSEcCtD
Pentazocine—Dermatitis—Eplerenone—hypertension	0.000174	0.000261	CcSEcCtD
Pentazocine—Diarrhoea—Valsartan—hypertension	0.000174	0.00026	CcSEcCtD
Pentazocine—Asthenia—Clonidine—hypertension	0.000174	0.00026	CcSEcCtD
Pentazocine—Feeling abnormal—Betaxolol—hypertension	0.000174	0.00026	CcSEcCtD
Pentazocine—Confusional state—Timolol—hypertension	0.000174	0.00026	CcSEcCtD
Pentazocine—Vomiting—Verapamil—hypertension	0.000174	0.00026	CcSEcCtD
Pentazocine—Shock—Ramipril—hypertension	0.000173	0.00026	CcSEcCtD
Pentazocine—Hypersensitivity—Enalapril—hypertension	0.000173	0.00026	CcSEcCtD
Pentazocine—Diarrhoea—Olmesartan—hypertension	0.000173	0.000259	CcSEcCtD
Pentazocine—Headache—Eplerenone—hypertension	0.000173	0.000259	CcSEcCtD
Pentazocine—Dermatitis—Nifedipine—hypertension	0.000173	0.000259	CcSEcCtD
Pentazocine—Anaphylactic shock—Timolol—hypertension	0.000172	0.000258	CcSEcCtD
Pentazocine—Loss of consciousness—Lisinopril—hypertension	0.000172	0.000258	CcSEcCtD
Pentazocine—Tachycardia—Ramipril—hypertension	0.000172	0.000258	CcSEcCtD
Pentazocine—Dermatitis—Verapamil—hypertension	0.000172	0.000258	CcSEcCtD
Pentazocine—Headache—Nifedipine—hypertension	0.000172	0.000257	CcSEcCtD
Pentazocine—Pruritus—Clonidine—hypertension	0.000171	0.000257	CcSEcCtD
Pentazocine—Headache—Verapamil—hypertension	0.000171	0.000256	CcSEcCtD
Pentazocine—Hypersensitivity—Telmisartan—hypertension	0.000171	0.000256	CcSEcCtD
Pentazocine—Nausea—Diltiazem—hypertension	0.000171	0.000256	CcSEcCtD
Pentazocine—Nausea—Indapamide—hypertension	0.000171	0.000256	CcSEcCtD
Pentazocine—Hyperhidrosis—Ramipril—hypertension	0.00017	0.000255	CcSEcCtD
Pentazocine—Asthenia—Trandolapril—hypertension	0.00017	0.000254	CcSEcCtD
Pentazocine—Shock—Timolol—hypertension	0.00017	0.000254	CcSEcCtD
Pentazocine—Feeling abnormal—Losartan—hypertension	0.000169	0.000254	CcSEcCtD
Pentazocine—Nausea—Carvedilol—hypertension	0.000169	0.000253	CcSEcCtD
Pentazocine—Asthenia—Enalapril—hypertension	0.000169	0.000253	CcSEcCtD
Pentazocine—Dizziness—Valsartan—hypertension	0.000168	0.000252	CcSEcCtD
Pentazocine—Anorexia—Ramipril—hypertension	0.000168	0.000252	CcSEcCtD
Pentazocine—Dizziness—Olmesartan—hypertension	0.000167	0.00025	CcSEcCtD
Pentazocine—Pruritus—Trandolapril—hypertension	0.000167	0.00025	CcSEcCtD
Pentazocine—Nausea—Doxazosin—hypertension	0.000167	0.00025	CcSEcCtD
Pentazocine—Hyperhidrosis—Timolol—hypertension	0.000167	0.000249	CcSEcCtD
Pentazocine—Asthenia—Telmisartan—hypertension	0.000167	0.000249	CcSEcCtD
Pentazocine—Pruritus—Enalapril—hypertension	0.000167	0.000249	CcSEcCtD
Pentazocine—Diarrhoea—Clonidine—hypertension	0.000166	0.000248	CcSEcCtD
Pentazocine—Nausea—Fosinopril—hypertension	0.000165	0.000247	CcSEcCtD
Pentazocine—Hypotension—Ramipril—hypertension	0.000165	0.000247	CcSEcCtD
Pentazocine—Anorexia—Timolol—hypertension	0.000164	0.000246	CcSEcCtD
Pentazocine—Pruritus—Telmisartan—hypertension	0.000164	0.000246	CcSEcCtD
Pentazocine—Nausea—Eplerenone—hypertension	0.000164	0.000246	CcSEcCtD
Pentazocine—Dry mouth—Lisinopril—hypertension	0.000163	0.000244	CcSEcCtD
Pentazocine—Nausea—Nifedipine—hypertension	0.000163	0.000244	CcSEcCtD
Pentazocine—Nausea—Verapamil—hypertension	0.000162	0.000243	CcSEcCtD
Pentazocine—Asthenia—Captopril—hypertension	0.000162	0.000243	CcSEcCtD
Pentazocine—Diarrhoea—Trandolapril—hypertension	0.000162	0.000242	CcSEcCtD
Pentazocine—Vomiting—Valsartan—hypertension	0.000162	0.000242	CcSEcCtD
Pentazocine—Confusional state—Lisinopril—hypertension	0.000161	0.000241	CcSEcCtD
Pentazocine—Diarrhoea—Enalapril—hypertension	0.000161	0.000241	CcSEcCtD
Pentazocine—Hypotension—Timolol—hypertension	0.000161	0.000241	CcSEcCtD
Pentazocine—Hypersensitivity—Irbesartan—hypertension	0.000161	0.000241	CcSEcCtD
Pentazocine—Vomiting—Olmesartan—hypertension	0.000161	0.000241	CcSEcCtD
Pentazocine—Dizziness—Clonidine—hypertension	0.00016	0.00024	CcSEcCtD
Pentazocine—Dermatitis—Valsartan—hypertension	0.00016	0.00024	CcSEcCtD
Pentazocine—Anaphylactic shock—Lisinopril—hypertension	0.00016	0.000239	CcSEcCtD
Pentazocine—Pruritus—Captopril—hypertension	0.00016	0.000239	CcSEcCtD
Pentazocine—Hypersensitivity—Hydrochlorothiazide—hypertension	0.00016	0.000239	CcSEcCtD
Pentazocine—Insomnia—Ramipril—hypertension	0.000159	0.000239	CcSEcCtD
Pentazocine—Dermatitis—Olmesartan—hypertension	0.000159	0.000239	CcSEcCtD
Pentazocine—Headache—Valsartan—hypertension	0.000159	0.000238	CcSEcCtD
Pentazocine—Diarrhoea—Telmisartan—hypertension	0.000159	0.000238	CcSEcCtD
Pentazocine—Headache—Olmesartan—hypertension	0.000158	0.000237	CcSEcCtD
Pentazocine—Paraesthesia—Ramipril—hypertension	0.000158	0.000237	CcSEcCtD
Pentazocine—Shock—Lisinopril—hypertension	0.000157	0.000235	CcSEcCtD
Pentazocine—Asthenia—Perindopril—hypertension	0.000157	0.000235	CcSEcCtD
Pentazocine—Dyspnoea—Ramipril—hypertension	0.000157	0.000235	CcSEcCtD
Pentazocine—Hypersensitivity—Furosemide—hypertension	0.000157	0.000235	CcSEcCtD
Pentazocine—Asthenia—Irbesartan—hypertension	0.000157	0.000235	CcSEcCtD
Pentazocine—Somnolence—Ramipril—hypertension	0.000157	0.000235	CcSEcCtD
Pentazocine—Dizziness—Trandolapril—hypertension	0.000156	0.000234	CcSEcCtD
Pentazocine—Tachycardia—Lisinopril—hypertension	0.000156	0.000234	CcSEcCtD
Pentazocine—Insomnia—Timolol—hypertension	0.000156	0.000233	CcSEcCtD
Pentazocine—Dizziness—Enalapril—hypertension	0.000156	0.000233	CcSEcCtD
Pentazocine—Asthenia—Hydrochlorothiazide—hypertension	0.000155	0.000233	CcSEcCtD
Pentazocine—Hypersensitivity—Betaxolol—hypertension	0.000155	0.000233	CcSEcCtD
Pentazocine—Pruritus—Perindopril—hypertension	0.000155	0.000232	CcSEcCtD
Pentazocine—Paraesthesia—Timolol—hypertension	0.000155	0.000232	CcSEcCtD
Pentazocine—Pruritus—Irbesartan—hypertension	0.000155	0.000231	CcSEcCtD
Pentazocine—Hyperhidrosis—Lisinopril—hypertension	0.000155	0.000231	CcSEcCtD
Pentazocine—Diarrhoea—Captopril—hypertension	0.000154	0.000231	CcSEcCtD
Pentazocine—Vomiting—Clonidine—hypertension	0.000154	0.000231	CcSEcCtD
Pentazocine—Dyspnoea—Timolol—hypertension	0.000154	0.00023	CcSEcCtD
Pentazocine—Dizziness—Telmisartan—hypertension	0.000154	0.00023	CcSEcCtD
Pentazocine—Pruritus—Hydrochlorothiazide—hypertension	0.000153	0.00023	CcSEcCtD
Pentazocine—Decreased appetite—Ramipril—hypertension	0.000153	0.000229	CcSEcCtD
Pentazocine—Somnolence—Timolol—hypertension	0.000153	0.000229	CcSEcCtD
Pentazocine—Asthenia—Furosemide—hypertension	0.000153	0.000229	CcSEcCtD
Pentazocine—Dermatitis—Clonidine—hypertension	0.000153	0.000229	CcSEcCtD
Pentazocine—Anorexia—Lisinopril—hypertension	0.000152	0.000228	CcSEcCtD
Pentazocine—Headache—Clonidine—hypertension	0.000152	0.000227	CcSEcCtD
Pentazocine—Hypersensitivity—Losartan—hypertension	0.000151	0.000227	CcSEcCtD
Pentazocine—Asthenia—Betaxolol—hypertension	0.000151	0.000227	CcSEcCtD
Pentazocine—Nausea—Valsartan—hypertension	0.000151	0.000226	CcSEcCtD
Pentazocine—Pruritus—Furosemide—hypertension	0.000151	0.000226	CcSEcCtD
Pentazocine—Constipation—Ramipril—hypertension	0.000151	0.000226	CcSEcCtD
Pentazocine—Nausea—Olmesartan—hypertension	0.00015	0.000225	CcSEcCtD
Pentazocine—Vomiting—Trandolapril—hypertension	0.00015	0.000225	CcSEcCtD
Pentazocine—Diarrhoea—Perindopril—hypertension	0.00015	0.000225	CcSEcCtD
Pentazocine—Decreased appetite—Timolol—hypertension	0.00015	0.000224	CcSEcCtD
Pentazocine—Vomiting—Enalapril—hypertension	0.00015	0.000224	CcSEcCtD
Pentazocine—Diarrhoea—Irbesartan—hypertension	0.000149	0.000224	CcSEcCtD
Pentazocine—Hypotension—Lisinopril—hypertension	0.000149	0.000224	CcSEcCtD
Pentazocine—Dizziness—Captopril—hypertension	0.000149	0.000224	CcSEcCtD
Pentazocine—Pruritus—Betaxolol—hypertension	0.000149	0.000223	CcSEcCtD
Pentazocine—Dermatitis—Trandolapril—hypertension	0.000149	0.000223	CcSEcCtD
Pentazocine—Dermatitis—Enalapril—hypertension	0.000148	0.000222	CcSEcCtD
Pentazocine—Diarrhoea—Hydrochlorothiazide—hypertension	0.000148	0.000222	CcSEcCtD
Pentazocine—Headache—Trandolapril—hypertension	0.000148	0.000222	CcSEcCtD
Pentazocine—Vomiting—Telmisartan—hypertension	0.000148	0.000221	CcSEcCtD
Pentazocine—Asthenia—Losartan—hypertension	0.000147	0.000221	CcSEcCtD
Pentazocine—Headache—Enalapril—hypertension	0.000147	0.000221	CcSEcCtD
Pentazocine—Dermatitis—Telmisartan—hypertension	0.000146	0.000219	CcSEcCtD
Pentazocine—Diarrhoea—Furosemide—hypertension	0.000146	0.000218	CcSEcCtD
Pentazocine—Pruritus—Losartan—hypertension	0.000145	0.000218	CcSEcCtD
Pentazocine—Headache—Telmisartan—hypertension	0.000145	0.000218	CcSEcCtD
Pentazocine—Feeling abnormal—Ramipril—hypertension	0.000145	0.000217	CcSEcCtD
Pentazocine—Dizziness—Perindopril—hypertension	0.000145	0.000217	CcSEcCtD
Pentazocine—Insomnia—Lisinopril—hypertension	0.000145	0.000216	CcSEcCtD
Pentazocine—Dizziness—Irbesartan—hypertension	0.000144	0.000216	CcSEcCtD
Pentazocine—Diarrhoea—Betaxolol—hypertension	0.000144	0.000216	CcSEcCtD
Pentazocine—Nausea—Clonidine—hypertension	0.000144	0.000215	CcSEcCtD
Pentazocine—Paraesthesia—Lisinopril—hypertension	0.000144	0.000215	CcSEcCtD
Pentazocine—Vomiting—Captopril—hypertension	0.000144	0.000215	CcSEcCtD
Pentazocine—Dizziness—Hydrochlorothiazide—hypertension	0.000143	0.000215	CcSEcCtD
Pentazocine—Dyspnoea—Lisinopril—hypertension	0.000143	0.000213	CcSEcCtD
Pentazocine—Dermatitis—Captopril—hypertension	0.000142	0.000213	CcSEcCtD
Pentazocine—Somnolence—Lisinopril—hypertension	0.000142	0.000213	CcSEcCtD
Pentazocine—Feeling abnormal—Timolol—hypertension	0.000142	0.000213	CcSEcCtD
Pentazocine—Headache—Captopril—hypertension	0.000141	0.000212	CcSEcCtD
Pentazocine—Dizziness—Furosemide—hypertension	0.000141	0.000211	CcSEcCtD
Pentazocine—Diarrhoea—Losartan—hypertension	0.000141	0.000211	CcSEcCtD
Pentazocine—Nausea—Trandolapril—hypertension	0.00014	0.00021	CcSEcCtD
Pentazocine—Nausea—Enalapril—hypertension	0.00014	0.000209	CcSEcCtD
Pentazocine—Dizziness—Betaxolol—hypertension	0.000139	0.000209	CcSEcCtD
Pentazocine—Vomiting—Perindopril—hypertension	0.000139	0.000209	CcSEcCtD
Pentazocine—Decreased appetite—Lisinopril—hypertension	0.000139	0.000208	CcSEcCtD
Pentazocine—Vomiting—Irbesartan—hypertension	0.000139	0.000208	CcSEcCtD
Pentazocine—Dermatitis—Perindopril—hypertension	0.000138	0.000207	CcSEcCtD
Pentazocine—Nausea—Telmisartan—hypertension	0.000138	0.000206	CcSEcCtD
Pentazocine—Vomiting—Hydrochlorothiazide—hypertension	0.000138	0.000206	CcSEcCtD
Pentazocine—OPRD1—kidney—hypertension	0.000138	0.0808	CbGeAlD
Pentazocine—Dermatitis—Irbesartan—hypertension	0.000138	0.000206	CcSEcCtD
Pentazocine—Headache—Perindopril—hypertension	0.000137	0.000206	CcSEcCtD
Pentazocine—Headache—Irbesartan—hypertension	0.000137	0.000205	CcSEcCtD
Pentazocine—Constipation—Lisinopril—hypertension	0.000137	0.000205	CcSEcCtD
Pentazocine—Dermatitis—Hydrochlorothiazide—hypertension	0.000136	0.000204	CcSEcCtD
Pentazocine—Dizziness—Losartan—hypertension	0.000136	0.000204	CcSEcCtD
Pentazocine—Headache—Hydrochlorothiazide—hypertension	0.000136	0.000203	CcSEcCtD
Pentazocine—Vomiting—Furosemide—hypertension	0.000135	0.000203	CcSEcCtD
Pentazocine—Dermatitis—Furosemide—hypertension	0.000134	0.000201	CcSEcCtD
Pentazocine—Vomiting—Betaxolol—hypertension	0.000134	0.000201	CcSEcCtD
Pentazocine—Nausea—Captopril—hypertension	0.000134	0.000201	CcSEcCtD
Pentazocine—Headache—Furosemide—hypertension	0.000133	0.0002	CcSEcCtD
Pentazocine—Dermatitis—Betaxolol—hypertension	0.000133	0.000199	CcSEcCtD
Pentazocine—Headache—Betaxolol—hypertension	0.000132	0.000198	CcSEcCtD
Pentazocine—Feeling abnormal—Lisinopril—hypertension	0.000132	0.000197	CcSEcCtD
Pentazocine—Vomiting—Losartan—hypertension	0.000131	0.000196	CcSEcCtD
Pentazocine—Nausea—Perindopril—hypertension	0.00013	0.000195	CcSEcCtD
Pentazocine—Hypersensitivity—Ramipril—hypertension	0.00013	0.000194	CcSEcCtD
Pentazocine—Nausea—Irbesartan—hypertension	0.00013	0.000194	CcSEcCtD
Pentazocine—Dermatitis—Losartan—hypertension	0.000129	0.000194	CcSEcCtD
Pentazocine—Headache—Losartan—hypertension	0.000129	0.000193	CcSEcCtD
Pentazocine—Nausea—Hydrochlorothiazide—hypertension	0.000129	0.000193	CcSEcCtD
Pentazocine—SIGMAR1—cardiac ventricle—hypertension	0.000128	0.0751	CbGeAlD
Pentazocine—Hypersensitivity—Timolol—hypertension	0.000127	0.00019	CcSEcCtD
Pentazocine—Nausea—Furosemide—hypertension	0.000127	0.000189	CcSEcCtD
Pentazocine—Asthenia—Ramipril—hypertension	0.000126	0.000189	CcSEcCtD
Pentazocine—Nausea—Betaxolol—hypertension	0.000125	0.000188	CcSEcCtD
Pentazocine—Pruritus—Ramipril—hypertension	0.000125	0.000187	CcSEcCtD
Pentazocine—Asthenia—Timolol—hypertension	0.000124	0.000185	CcSEcCtD
Pentazocine—Nausea—Losartan—hypertension	0.000122	0.000183	CcSEcCtD
Pentazocine—Pruritus—Timolol—hypertension	0.000122	0.000183	CcSEcCtD
Pentazocine—Diarrhoea—Ramipril—hypertension	0.000121	0.000181	CcSEcCtD
Pentazocine—SIGMAR1—myocardium—hypertension	0.00012	0.0707	CbGeAlD
Pentazocine—Diarrhoea—Timolol—hypertension	0.000118	0.000177	CcSEcCtD
Pentazocine—Hypersensitivity—Lisinopril—hypertension	0.000118	0.000176	CcSEcCtD
Pentazocine—OPRM1—brainstem—hypertension	0.000118	0.0691	CbGeAlD
Pentazocine—Dizziness—Ramipril—hypertension	0.000117	0.000175	CcSEcCtD
Pentazocine—Asthenia—Lisinopril—hypertension	0.000115	0.000172	CcSEcCtD
Pentazocine—Dizziness—Timolol—hypertension	0.000114	0.000171	CcSEcCtD
Pentazocine—Pruritus—Lisinopril—hypertension	0.000113	0.000169	CcSEcCtD
Pentazocine—Vomiting—Ramipril—hypertension	0.000112	0.000168	CcSEcCtD
Pentazocine—Dermatitis—Ramipril—hypertension	0.000111	0.000166	CcSEcCtD
Pentazocine—Headache—Ramipril—hypertension	0.00011	0.000165	CcSEcCtD
Pentazocine—Vomiting—Timolol—hypertension	0.00011	0.000164	CcSEcCtD
Pentazocine—Diarrhoea—Lisinopril—hypertension	0.000109	0.000164	CcSEcCtD
Pentazocine—Dermatitis—Timolol—hypertension	0.000109	0.000163	CcSEcCtD
Pentazocine—Headache—Timolol—hypertension	0.000108	0.000162	CcSEcCtD
Pentazocine—Dizziness—Lisinopril—hypertension	0.000106	0.000158	CcSEcCtD
Pentazocine—Nausea—Ramipril—hypertension	0.000105	0.000157	CcSEcCtD
Pentazocine—Nausea—Timolol—hypertension	0.000102	0.000153	CcSEcCtD
Pentazocine—Vomiting—Lisinopril—hypertension	0.000102	0.000152	CcSEcCtD
Pentazocine—Dermatitis—Lisinopril—hypertension	0.000101	0.000151	CcSEcCtD
Pentazocine—Headache—Lisinopril—hypertension	0.0001	0.00015	CcSEcCtD
Pentazocine—Nausea—Lisinopril—hypertension	9.5e-05	0.000142	CcSEcCtD
Pentazocine—SIGMAR1—nephron tubule—hypertension	8.82e-05	0.0518	CbGeAlD
Pentazocine—OPRD1—central nervous system—hypertension	8.7e-05	0.0511	CbGeAlD
Pentazocine—SIGMAR1—adrenal cortex—hypertension	8.69e-05	0.051	CbGeAlD
Pentazocine—SIGMAR1—heart—hypertension	8.4e-05	0.0493	CbGeAlD
Pentazocine—OPRK1—central nervous system—hypertension	8.34e-05	0.049	CbGeAlD
Pentazocine—SIGMAR1—smooth muscle tissue—hypertension	8.33e-05	0.0489	CbGeAlD
Pentazocine—SIGMAR1—decidua—hypertension	8.17e-05	0.048	CbGeAlD
Pentazocine—SIGMAR1—cortex of kidney—hypertension	7.55e-05	0.0444	CbGeAlD
Pentazocine—SIGMAR1—cardiac atrium—hypertension	7.18e-05	0.0422	CbGeAlD
Pentazocine—SIGMAR1—medulla oblongata—hypertension	6.77e-05	0.0398	CbGeAlD
Pentazocine—OPRM1—endocrine gland—hypertension	6.58e-05	0.0387	CbGeAlD
Pentazocine—SIGMAR1—adrenal gland—hypertension	6.27e-05	0.0368	CbGeAlD
Pentazocine—OPRM1—central nervous system—hypertension	5.93e-05	0.0348	CbGeAlD
Pentazocine—OPRK1—Signaling Pathways—PLG—hypertension	2.88e-05	8.85e-05	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—CXCL8—hypertension	2.88e-05	8.85e-05	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—RHOA—hypertension	2.88e-05	8.84e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRA2A—hypertension	2.88e-05	8.84e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GHRL—hypertension	2.87e-05	8.8e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLAT—hypertension	2.87e-05	8.8e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EDN1—hypertension	2.86e-05	8.78e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT2—hypertension	2.85e-05	8.76e-05	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—PIK3R1—hypertension	2.85e-05	8.75e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL5—hypertension	2.84e-05	8.72e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CALCA—hypertension	2.83e-05	8.69e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADRB2—hypertension	2.81e-05	8.62e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LPL—hypertension	2.78e-05	8.52e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCE—hypertension	2.77e-05	8.51e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—BDKRB2—hypertension	2.76e-05	8.49e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—POMC—hypertension	2.76e-05	8.48e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—H2AFX—hypertension	2.76e-05	8.46e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—F2—hypertension	2.75e-05	8.45e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PRKCB—hypertension	2.75e-05	8.45e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RPS6KB1—hypertension	2.75e-05	8.45e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PDGFRB—hypertension	2.75e-05	8.45e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PDGFA—hypertension	2.74e-05	8.41e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VAV3—hypertension	2.74e-05	8.41e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRBK1—hypertension	2.73e-05	8.4e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ADCY5—hypertension	2.72e-05	8.34e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CNR1—hypertension	2.71e-05	8.33e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCG—hypertension	2.7e-05	8.29e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFBR2—hypertension	2.7e-05	8.29e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CALM2—hypertension	2.68e-05	8.25e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCA—hypertension	2.68e-05	8.23e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—ITGB3—hypertension	2.68e-05	8.23e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GNB3—hypertension	2.67e-05	8.21e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—YWHAZ—hypertension	2.66e-05	8.16e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT2—hypertension	2.65e-05	8.15e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—DRD2—hypertension	2.65e-05	8.13e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR7—hypertension	2.65e-05	8.13e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AVP—hypertension	2.64e-05	8.1e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NGF—hypertension	2.63e-05	8.07e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SPP1—hypertension	2.63e-05	8.07e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GCG—hypertension	2.62e-05	8.05e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTPN1—hypertension	2.62e-05	8.05e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—CXCL8—hypertension	2.62e-05	8.04e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—RHOA—hypertension	2.61e-05	8.03e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—GNAS—hypertension	2.6e-05	7.99e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—PIK3R1—hypertension	2.59e-05	7.94e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOTCH2—hypertension	2.57e-05	7.89e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KL—hypertension	2.57e-05	7.89e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCD—hypertension	2.56e-05	7.85e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCR5—hypertension	2.56e-05	7.85e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOB—hypertension	2.55e-05	7.83e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTK2—hypertension	2.54e-05	7.8e-05	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—CXCL8—hypertension	2.53e-05	7.76e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NGFR—hypertension	2.52e-05	7.75e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ITGAV—hypertension	2.52e-05	7.75e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KNG1—hypertension	2.52e-05	7.73e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EDN1—hypertension	2.51e-05	7.7e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—POMC—hypertension	2.51e-05	7.7e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HTR2A—hypertension	2.5e-05	7.68e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGTR1—hypertension	2.5e-05	7.68e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRL—hypertension	2.5e-05	7.68e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—C3—hypertension	2.5e-05	7.67e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL5—hypertension	2.49e-05	7.64e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HDAC1—hypertension	2.46e-05	7.57e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—STK11—hypertension	2.46e-05	7.57e-05	CbGpPWpGaD
Pentazocine—EBP—Metabolism—AKT1—hypertension	2.45e-05	7.54e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CCL2—hypertension	2.45e-05	7.53e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL10—hypertension	2.44e-05	7.5e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PLG—hypertension	2.44e-05	7.48e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LPL—hypertension	2.43e-05	7.47e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—RHOA—hypertension	2.43e-05	7.47e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PDGFB—hypertension	2.43e-05	7.47e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGFR1—hypertension	2.42e-05	7.43e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—H2AFX—hypertension	2.42e-05	7.42e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PDGFRB—hypertension	2.41e-05	7.41e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RPS6KB1—hypertension	2.41e-05	7.41e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT2—hypertension	2.41e-05	7.4e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—PIK3R1—hypertension	2.41e-05	7.39e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—HIF1A—hypertension	2.38e-05	7.32e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ADCY5—hypertension	2.38e-05	7.32e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AGT—hypertension	2.37e-05	7.29e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADRB2—hypertension	2.37e-05	7.29e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCG—hypertension	2.37e-05	7.27e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—ITGB3—hypertension	2.35e-05	7.22e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCA—hypertension	2.35e-05	7.22e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCE—hypertension	2.34e-05	7.19e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CALM1—hypertension	2.33e-05	7.17e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—YWHAZ—hypertension	2.33e-05	7.16e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—LEP—hypertension	2.33e-05	7.14e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOE—hypertension	2.33e-05	7.14e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VAV3—hypertension	2.31e-05	7.1e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDGFA—hypertension	2.31e-05	7.1e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NGF—hypertension	2.3e-05	7.08e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SPP1—hypertension	2.3e-05	7.08e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CAV1—hypertension	2.3e-05	7.08e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—APOA1—hypertension	2.3e-05	7.06e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—CXCL8—hypertension	2.29e-05	7.05e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFBR2—hypertension	2.28e-05	7e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—KDR—hypertension	2.28e-05	7e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GNB3—hypertension	2.26e-05	6.94e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCR5—hypertension	2.24e-05	6.89e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCD—hypertension	2.24e-05	6.89e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AVP—hypertension	2.23e-05	6.84e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—RHOA—hypertension	2.21e-05	6.78e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—GNAS—hypertension	2.2e-05	6.76e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HTR2A—hypertension	2.19e-05	6.74e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—F2—hypertension	2.19e-05	6.74e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PRKCB—hypertension	2.19e-05	6.74e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FN1—hypertension	2.19e-05	6.74e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—C3—hypertension	2.19e-05	6.73e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—PIK3R1—hypertension	2.19e-05	6.71e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOB—hypertension	2.15e-05	6.62e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOTCH1—hypertension	2.15e-05	6.59e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTK2—hypertension	2.15e-05	6.59e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—CXCL8—hypertension	2.14e-05	6.56e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PDGFB—hypertension	2.13e-05	6.55e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGFR1—hypertension	2.12e-05	6.52e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EDN1—hypertension	2.12e-05	6.51e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL5—hypertension	2.1e-05	6.46e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—HIF1A—hypertension	2.09e-05	6.42e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AGT—hypertension	2.08e-05	6.39e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LPL—hypertension	2.06e-05	6.32e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CALM1—hypertension	2.05e-05	6.29e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—H2AFX—hypertension	2.04e-05	6.27e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOE—hypertension	2.04e-05	6.26e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—LEP—hypertension	2.04e-05	6.26e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDGFRB—hypertension	2.04e-05	6.26e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RPS6KB1—hypertension	2.04e-05	6.26e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CAV1—hypertension	2.02e-05	6.21e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—APOA1—hypertension	2.02e-05	6.19e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ADCY5—hypertension	2.01e-05	6.18e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCG—hypertension	2e-05	6.14e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—KDR—hypertension	2e-05	6.14e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—POMC—hypertension	2e-05	6.14e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—INS—hypertension	1.99e-05	6.1e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—ITGB3—hypertension	1.99e-05	6.1e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCA—hypertension	1.99e-05	6.1e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—YWHAZ—hypertension	1.97e-05	6.05e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CCL2—hypertension	1.96e-05	6.01e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NGF—hypertension	1.95e-05	5.98e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SPP1—hypertension	1.95e-05	5.98e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—CXCL8—hypertension	1.94e-05	5.96e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PRKCB—hypertension	1.92e-05	5.91e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—F2—hypertension	1.92e-05	5.91e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FN1—hypertension	1.92e-05	5.91e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IGF1—hypertension	1.92e-05	5.9e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT2—hypertension	1.92e-05	5.9e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—EGFR—hypertension	1.91e-05	5.87e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCR5—hypertension	1.89e-05	5.82e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCD—hypertension	1.89e-05	5.82e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOTCH1—hypertension	1.88e-05	5.78e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HTR2A—hypertension	1.85e-05	5.7e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—C3—hypertension	1.85e-05	5.69e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SERPINE1—hypertension	1.83e-05	5.61e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PDGFB—hypertension	1.8e-05	5.54e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGFR1—hypertension	1.79e-05	5.51e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—FGF2—hypertension	1.77e-05	5.43e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—HIF1A—hypertension	1.77e-05	5.42e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RHOA—hypertension	1.76e-05	5.41e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AGT—hypertension	1.76e-05	5.4e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—POMC—hypertension	1.75e-05	5.38e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PIK3R1—hypertension	1.74e-05	5.35e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—NOS3—hypertension	1.74e-05	5.35e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—INS—hypertension	1.74e-05	5.35e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CALM1—hypertension	1.73e-05	5.31e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOE—hypertension	1.72e-05	5.29e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—LEP—hypertension	1.72e-05	5.29e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CCL2—hypertension	1.71e-05	5.27e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CAV1—hypertension	1.71e-05	5.25e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—APOA1—hypertension	1.7e-05	5.23e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—KDR—hypertension	1.69e-05	5.19e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IGF1—hypertension	1.69e-05	5.18e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT2—hypertension	1.68e-05	5.17e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—EGFR—hypertension	1.68e-05	5.15e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—RELA—hypertension	1.64e-05	5.04e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—F2—hypertension	1.63e-05	4.99e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PRKCB—hypertension	1.63e-05	4.99e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FN1—hypertension	1.63e-05	4.99e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MTOR—hypertension	1.61e-05	4.94e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SERPINE1—hypertension	1.6e-05	4.92e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOTCH1—hypertension	1.59e-05	4.89e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—FGF2—hypertension	1.55e-05	4.76e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CXCL8—hypertension	1.55e-05	4.75e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RHOA—hypertension	1.54e-05	4.74e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—NOS3—hypertension	1.53e-05	4.69e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PIK3R1—hypertension	1.53e-05	4.69e-05	CbGpPWpGaD
Pentazocine—OPRD1—GPCR downstream signaling—AKT1—hypertension	1.49e-05	4.59e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—POMC—hypertension	1.48e-05	4.55e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—INS—hypertension	1.47e-05	4.52e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—IL6—hypertension	1.47e-05	4.51e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CCL2—hypertension	1.45e-05	4.45e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—RELA—hypertension	1.44e-05	4.42e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IGF1—hypertension	1.42e-05	4.38e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT2—hypertension	1.42e-05	4.37e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—EGFR—hypertension	1.42e-05	4.35e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MTOR—hypertension	1.41e-05	4.33e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MMP9—hypertension	1.4e-05	4.29e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—CDKN1A—hypertension	1.39e-05	4.28e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—PTEN—hypertension	1.39e-05	4.27e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MAPK8—hypertension	1.36e-05	4.18e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling by GPCR—AKT1—hypertension	1.36e-05	4.16e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CXCL8—hypertension	1.36e-05	4.16e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SERPINE1—hypertension	1.35e-05	4.15e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EP300—hypertension	1.33e-05	4.07e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—FGF2—hypertension	1.31e-05	4.02e-05	CbGpPWpGaD
Pentazocine—OPRK1—GPCR downstream signaling—AKT1—hypertension	1.31e-05	4.02e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RHOA—hypertension	1.3e-05	4.01e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PIK3R1—hypertension	1.29e-05	3.97e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—NOS3—hypertension	1.29e-05	3.97e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—SRC—hypertension	1.29e-05	3.96e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—IL6—hypertension	1.29e-05	3.96e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—VEGFA—hypertension	1.26e-05	3.86e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MMP9—hypertension	1.23e-05	3.77e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—CDKN1A—hypertension	1.22e-05	3.75e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—PTEN—hypertension	1.22e-05	3.74e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—RELA—hypertension	1.22e-05	3.73e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MAPK8—hypertension	1.19e-05	3.66e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MTOR—hypertension	1.19e-05	3.66e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling by GPCR—AKT1—hypertension	1.19e-05	3.65e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EP300—hypertension	1.16e-05	3.57e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—MYC—hypertension	1.16e-05	3.55e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TGFB1—hypertension	1.15e-05	3.54e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CXCL8—hypertension	1.15e-05	3.52e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—SRC—hypertension	1.13e-05	3.47e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—EGFR—hypertension	1.13e-05	3.47e-05	CbGpPWpGaD
Pentazocine—OPRM1—GPCR downstream signaling—AKT1—hypertension	1.11e-05	3.4e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—VEGFA—hypertension	1.1e-05	3.38e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—IL6—hypertension	1.09e-05	3.35e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MMP9—hypertension	1.04e-05	3.18e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—CDKN1A—hypertension	1.03e-05	3.17e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—PTEN—hypertension	1.03e-05	3.16e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—MYC—hypertension	1.01e-05	3.11e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TGFB1—hypertension	1.01e-05	3.1e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MAPK8—hypertension	1.01e-05	3.1e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling by GPCR—AKT1—hypertension	1e-05	3.09e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—EGFR—hypertension	9.91e-06	3.04e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EP300—hypertension	9.82e-06	3.02e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—SRC—hypertension	9.55e-06	2.93e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—TP53—hypertension	9.49e-06	2.91e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—VEGFA—hypertension	9.3e-06	2.86e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—IL6—hypertension	8.68e-06	2.67e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—MYC—hypertension	8.56e-06	2.63e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TGFB1—hypertension	8.54e-06	2.62e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—EGFR—hypertension	8.37e-06	2.57e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—TP53—hypertension	8.32e-06	2.55e-05	CbGpPWpGaD
Pentazocine—OPRD1—Signaling Pathways—AKT1—hypertension	8.01e-06	2.46e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—IL6—hypertension	7.61e-06	2.34e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—TP53—hypertension	7.03e-06	2.16e-05	CbGpPWpGaD
Pentazocine—OPRK1—Signaling Pathways—AKT1—hypertension	7.02e-06	2.16e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—IL6—hypertension	6.44e-06	1.98e-05	CbGpPWpGaD
Pentazocine—OPRM1—Signaling Pathways—AKT1—hypertension	5.94e-06	1.82e-05	CbGpPWpGaD
